18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells.
Ying-Hua LuoCheng WangWan-Ting XuYu ZhangTong ZhangHui XueYan-Nan LiZhong-Ren FuYing WangCheng-Hao JinPublished in: OncoTargets and therapy (2021)
In summary, 18β-Gly induced apoptosis and G2/M cell cycle arrest and inhibited migration via the ROS/MAPK/STAT3/NF-κB signaling pathways in A549 lung cancer cells. Therefore, 18β-Gly is a novel promising candidate for the treatment of lung cancer.